Breadcrumb links

Navigation

New stem cell partnership between the MRC and the National Natural Science Foundation of China

31 July 2012

 

The UK Medical Research Council (MRC) and the National Natural Science Foundation of China (NSFC) have announced nine new funding awards to address key knowledge gaps in stem cell research and improve collaborative links between scientists in the UK and China.

 

The scheme provides financial support to establish small scale collaborative projects between research laboratories in the UK and China, and will increase our understanding of stem cell biology and undertake preliminary, pre-clinical studies to underpin therapeutic development in the future.

 

In the longer term the awards made under this initiative will provide a foundation for the development of more substantive stem cell research programmes between the two countries.

 

Dr Rob Buckle, Head of Regenerative Medicine at the Medical Research Council, said:

“The rapid-development of stem cell research over the last decade has already led to many fruitful international collaborations. We look forward to maximising the opportunities for UK and Chinese researchers to establish long-term partnerships which will increase our understanding of stem cell biology and how it can best be exploited to improve human health, through both the modelling of disease in the laboratory and the development of new treatments.”

 

By bringing together eminent research groups between the two countries, the initiative will build on their strengths and accelerate progress in this area.

 

The nine funded projects are:

  • 1. Epigenetic control of stem cell activity during epithelial tissue regeneration
  • 2. Polycomb repressive complex 2 regulation of neurogenesis
  • 3. Functional study of mitotic checkpoint in human embryonic stem cells
  • 4. Steroid receptors as targets for myelin regeneration by endogenous adult neural stem cells
  • 5. The role of pro-inflammatory mesenchymal stem cells in rheumatoid arthritis
  • 6. Investigation of factors that prevent endogenous regeneration of the retina by Müller stem cells
  • 7. Characterisation of the motor neurons obtained from induced pluripotent stem cells (iPS) in Amyotrophic Lateral Sclerosis (ALS)
  • 8. Development of novel in vitro models for Hepatitis B Virus and Hepatitis C Virus Infection and Replication
  • 9. Developing stem cell therapies for the treatment of inherited and acquired liver disease
  •  

    MRC YouTube channel

                
    Contact Us
    • Comment?
    • Question?
    • Request?
    • Complaint?

    Get in touch

    This page as PDF